FSTL3 can be implicated in these phenotypes via the nuclear receptor transcription factor retinoic acid receptor (RARα), which can interact with target genes to regulate normal physiological processes, tumor growth, metastasis, drug resistance, and other processes (Khetchoumian et al., 2008). This evidence concerns the gene FSTL3 and neoplasm.